Zentiva completed the acquisition of Turkish drugmaker Eczacibasi Generic Pharmaceuticals – according to the company’s statement released yesterday. Our view: We see the news as neutral, as the closing date of the transaction is in-line with the indicated date by Zentiva. It shows us that the acquisition is on the right track, and we can continue to assume that Zentiva will consolidate Eczacibasi’s earnings from 2H07, in-line with the market’s expectation.